1. Adamson, A. and A. Shearn. 1996. Molecular Genetic Analysis of Drosophila ash2, a Member of the Trithorax Group that is Required for Imaginal Disc Pattern Formation. Genetics 144:621-633.
  2. Adamson, A. and S. Kenney. 1998. Rescue of the Epstein-Barr Virus BZLF1 Mutant, Z(S186A), Early Gene Activation Defect by the BRLF1 Gene Product. Virology 251:187-197.
  3. Adamson, A. and S. Kenney. 1999. The Epstein-Barr Virus BZLF1 Protein Interacts Physically and Functionally with the Histone Acetylase CREB-Binding Protein. Journal of Virology 73:6551-6558.
  4. Adamson, A., D. Darr, E. Holley-Guthrie, R. A. Johnson, A. Mauser, J. Swenson, and S. Kenney. 2000. Epstein-Barr Virus Immediate-Early Proteins BZLF1 and BRLF1 Activate the ATF2 Transcription Factor by Increasing the Levels of Phosphorylated p38 and c-Jun N-Terminal Kinases. Journal of Virology 74:1224-1233.
  5. Adamson, A. and S. Kenney. 2001. The Epstein-Barr Virus (EBV) Immediate-Early Protein, BZLF1, is SUMO-1-modified and disrupts PML bodies. Journal of Virology 75:2388-2399.
  6. Adamson, A., N. Wright, and D. LaJeunesse. 2005. Modeling Early Epstein-Barr Viral Infection in Drosophila melanogaster: The BZLF1 Protein. Genetics 171:1125-1135. 
  7. Adamson, A.  2005.  Epstein-Barr virus BZLF1 protein binds to mitotic chromosomes.  Journal of Virology 79(12):7899-7904.
  8. LaJeunesse, D., K. Brooks, and A. Adamson. 2005. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 alter mitochondrial morphology during lytic replication. Biochemical and Biophysical Research Communications 333:438-442.
  9. Adamson, A.  2005. Effects of SUMO-1 upon Epstein-Barr Virus BZLF1 Function and BMRF1 Expression. Biochemical and Biophysical Research Communications 336:22-28.
  10. Bowling, B. and A. Adamson. 2006. Functional interactions between the Epstein-Barr virus BZLF1 protein and the promyelocytic leukemia protein.  Virus Research 117:244-253.
  11. Adamson, A., Chohan, K., Kincaid, J., and LaJeunesse D. 2011.  A Drosophila Model for Genetic Analysis of Influenza Viral/Host Interactions.  Genetics 189: 495-506.
  12. Adamson, A., and LaJeunesse D.  2012. A Study of Epstein-Barr Virus BRLF1 Activity in a Drosophila Model System. The Scientific World Journal – Cell Biology Domain 2012:1-9.
  13. Adamson, A. 2013. Identification of an N-acetylglucosaminyltranferase-IV as a modifier of Epstein-Barr virus BZLF1 activity. Open Journal of Genetics 3(1) 1-5.
  14. Kohio, H. and A. Adamson. 2013. Glycolytic Control of Vacuolar-Type ATPase Activity: A Mechanism to Regulate Influenza Viral Infection. Virology 444: 301-309.
  15. Adamson, A., B. Le, and B. Siedenburg. 2014. Inhibition of mTOR inhibits lytic replication of Epstein-Barr virus in a cell-type specific manner. Virology Journal 11:110.
  16. Adamson, A., B Siedenburg, and A. Tognasoli.  2016. Epstein-Barr virus activation of downstream targets of the mTORC1 and MAPK pathways during lytic replication is dependent upon mTOR activity in a cell-type dependent manner.  Under revision.
  17. Covell, A., Zeng, Z., Wei, J., Adamson A., and LaJeunesse, D. 2016. Alternative SiO2 surface energies direct MCDK epithelial behavior. Submitted to Biomaterials Acta.
  18. Adamson, A. and J. Ray. 2016. Knockdown of the V1A subunit of the vacuolar V1V0-ATPase proton pump reduces infection by Influenza A virus. Submitted to Virus Research.
  19. Needham, J. and A. Adamson. 2016.  BZLF1 Transcript Variants in Epstein-Barr Virus-Positive Epithelial Cell Lines. Submitted to Virology Reports.
  20. Needham, J. and A. Adamson.  2017.  The transcription factor YY1 mediates Epstein-Barr virus sensitivity to mTOR inhibition.  In preparation.